702800002: Alogliptin benzoate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Substance with hydrolase inhibitor mechanism of action (substance)\Peptide hydrolase inhibitor\Substance with dipeptidyl peptidase IV inhibitor mechanism of action (substance)\Alogliptin benzoate

\Drug or medicament (substance)\Alogliptin benzoate

\Substance categorised by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\...

\Pyrimidine and/or pyrimidine derivative\Pyrimidine\Alogliptin benzoate

\Pyridine and/or pyridine derivative\Piperidine\Alogliptin benzoate

\Organic compound\Organic cyclic compound\Heterocyclic compound (substance)\Pyrimidine and/or pyrimidine derivative\Pyrimidine\Alogliptin benzoate
\Organic compound\Organic cyclic compound\Heterocyclic compound (substance)\Pyridine and/or pyridine derivative\Piperidine\Alogliptin benzoate
\Organic compound\Organic nitrogen compound\Pyrimidine and/or pyrimidine derivative\Pyrimidine\Alogliptin benzoate
\Organic compound\Organic nitrogen compound\Pyridine and/or pyridine derivative\Piperidine\Alogliptin benzoate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2014. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Alogliptin benzoate	Is a	Alogliptin	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Alogliptin benzoate	Has disposition	Dipeptidyl peptidase IV inhibitor (disposition)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Alogliptin benzoate	Is a	Substance with dipeptidyl peptidase IV inhibitor mechanism of action (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Alogliptin benzoate	Is modification of (attribute)	Alogliptin	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Alogliptin benzoate	Is a	produit chimique catégorisé selon sa fonction	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Alogliptin benzoate	Is a	Enzyme inhibitor	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Alogliptin benzoate	Is a	Pyrimidine	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Alogliptin benzoate	Is a	Piperidine	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Alogliptin benzoate	Is a	Drug or medicament (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely alogliptin benzoate 6.25 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely alogliptin benzoate 12.5 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely alogliptin benzoate 25 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely alogliptin benzoate 6.25 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely alogliptin benzoate 6.25 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely alogliptin benzoate 12.5 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely alogliptin benzoate 12.5 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely alogliptin benzoate 25 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely alogliptin benzoate 25 milligram/1 each conventional release oral tablet	Has basis of strength substance (attribute)	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely alogliptin benzoate 25 milligram/1 each conventional release oral tablet	Has precise active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely alogliptin benzoate 12.5 milligram/1 each conventional release oral tablet	Has precise active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely alogliptin benzoate 6.25 milligram/1 each conventional release oral tablet	Has precise active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Alogliptin (as alogliptin benzoate) 6.25 mg oral tablet	Has precise active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Alogliptin (as alogliptin benzoate) 25 mg oral tablet	Has precise active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Alogliptin (as alogliptin benzoate) 12.5 mg and metformin hydrochloride 850 mg oral tablet	Has precise active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Alogliptin (as alogliptin benzoate) 12.5 mg and metformin hydrochloride 1 g oral tablet	Has precise active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Alogliptin (as alogliptin benzoate) 12.5 mg and metformin hydrochloride 500 mg oral tablet	Has precise active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet	Has precise active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 45 mg oral tablet	Has precise active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier (core metadata concept)	2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3006159012	Alogliptin benzoate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3006161015	Alogliptin benzoate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3006159012	Alogliptin benzoate (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3006159012	Alogliptin benzoate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3006161015	Alogliptin benzoate	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3006161015	Alogliptin benzoate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
790211000172117	benzoate d'alogliptine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
790211000172117	benzoate d'alogliptine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module